Similar articles

• Levamisole and cell-mediated immunity.

  Churchill WH Jr, David JR. Churchill WH Jr, et al. N Engl J Med. 1973 Aug 16;289(7):375-6. doi: 10.1056/NEJM197308162890715. N Engl J Med. 1973. PMID: 4718520 No abstract available.
• [Clinical use of levamisole - perspectives and warnings].

  Farber NA. Farber NA. Ter Arkh. 1980;52(1):95-100. Ter Arkh. 1980. PMID: 7368132 Russian. No abstract available.
• Cellular immune reactivity in patients with rheumatoid arthritis and effects of levamisole.

  Basch CM, Spitler LE, Engleman EG, Engleman EP. Basch CM, et al. J Rheumatol. 1977 Winter;4(4):377-88. J Rheumatol. 1977. PMID: 604477
• Levamisole in the modulation of the immune response: the current experimental and clinical state.

  Symoens J, Rosenthal M. Symoens J, et al. J Reticuloendothel Soc. 1977 Mar;21(3):175-221. J Reticuloendothel Soc. 1977. PMID: 142150 Review. No abstract available.
• [Levamisole -- a drug modifying immunologic phenomena].

  Bogdanikowa B. Bogdanikowa B. Postepy Hig Med Dosw. 1979 Mar-Apr;33(2):125-46. Postepy Hig Med Dosw. 1979. PMID: 384382 Review. Polish. No abstract available.